A year ago, DeepSeek’s R1 model triggered a massive sell-off, wiping nearly $600 billion from Nvidia’s value in a single day. Since then, the Chinese lab has released seven new models, but none have moved the market needle. The initial shock has worn off, and the narrative has fundamentally changed.
Authorities across the globe are launching investigations into X after its Grok AI chatbot was used to create and share nonconsensual, explicit images. The fallout includes urgent demands from India and a scathing condemnation from the European Commission. Elon Musk’s response has only added fuel to
Microsoft has acquired Osmos, a small Seattle startup focused on automating data engineering tasks. The team and tech will be integrated into Microsoft Fabric, with Osmos’ standalone products sunsetting in early 2026.
Prediction markets like Polymarket and Kalshi are now each valued over $10 billion, with weekly trading in the billions. But behind the hype of “truth machines” lies a world of insider trading, absurd bets, and regulatory uncertainty. Is this the future of finance or just another speculative bubble?
AI software developer Iterate.ai is making a massive pivot to a channel-first model. CEO Jon Nordmark expects partner-driven revenue to jump from 20% to 95% by 2027, fueled by demand for private, on-premises AI solutions.
Stord, the Atlanta-based startup challenging Amazon’s logistics dominance, has acquired the AI fulfillment platform Shipwire. The deal adds significant scale to Stord’s network as it continues its aggressive expansion.
Microsoft has made its Seeing AI app completely free. The AI-powered tool acts as a talking camera, describing text, people, and surroundings for users who are blind or have low vision.
Trucking companies are using AI to automate driver onboarding and compliance. This tackles a massive administrative burden in an industry with over 90% annual driver turnover. The goal is to turn safety compliance from a bottleneck into a competitive advantage.
A new analysis argues our entire infection prevention playbook is obsolete. With one in six bacterial infections now resistant and some battlefield wounds untreatable, the focus must shift from antibiotics to a new, lasting defense on skin and surfaces.
Major hospital systems are deploying AI to read scans, write insurance appeals, and transcribe visits, cutting some tasks by 50%. But the tech is also fabricating medical studies and creating new risks, forcing a “trust but verify” approach.
